Page last updated: 2024-10-26

3,4-dihydroxybenzohydroxamic acid and Liver Neoplasms

3,4-dihydroxybenzohydroxamic acid has been researched along with Liver Neoplasms in 1 studies

Liver Neoplasms: Tumors or cancer of the LIVER.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Abd, AM1
Al-Abbasi, FA1
Asaad, GF1
Abdel-Naim, AB1

Other Studies

1 other study available for 3,4-dihydroxybenzohydroxamic acid and Liver Neoplasms

ArticleYear
Didox potentiates the cytotoxic profile of doxorubicin and protects from its cardiotoxicity.
    European journal of pharmacology, 2013, Oct-15, Volume: 718, Issue:1-3

    Topics: Animals; Cardiotonic Agents; Caspase 3; Cell Cycle; Cell Line, Tumor; Doxorubicin; Drug Synergism; H

2013